Then, PAK6 inhibited the anti-hypertrophy effect of miR-214-3p in cardiomyocytes, the conclusion showing that PAK6 participated in miR-214-3p-mediated cardiac hypertrophy progress. The gene discussed is PAK6; the disease is cardiac hypertrophy.